Efficacy [qlco]
Water [inch, phsu]
Extract [sbst]
Bark, Stem [plnt]
Terminalia arjuna [plnt]
Patients [podg]
Chronic heart failure [dsyn]
DOUBLE BLIND [resa]
randomized controlled trial [inpr, resa]
Bark, Stem [plnt]
Terminalia arjuna [plnt]
Indian [popg]
System [ftcn]
Medicine [phsu]
ayurveda [bmod]
treatment [ftcn]
Various [irda]
Cardiac Diseases [dsyn]
Including [ftcn]
Heart failure [dsyn]
Well [qlco]
Design [acty]
Clinical Trials [resa]
Efficacy [qlco]
Safety [hcpp]
Chronic heart failure [dsyn]
Lacking [qlco]
Purpose [ftcn]
ADD [mobd]
Efficacy [qlco]
Safety [hcpp]
Water [inch, phsu]
Extract [sbst]
Bark, Stem [plnt]
Extract [sbst]
Chronic heart failure [dsyn]
Patients [podg]
Standard [qlco]
Pharmacotherapy [topp]
Study Design [resa]
DOUBLE BLIND [resa]
Parallel [qlco]
randomized [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
ADD [mobd]
Methods [inpr]
Approval [qlco]
Institutional Ethics Committee [prog]
Patients [podg]
Chronic heart failure [dsyn]
New York Heart Association Class II [fndg]
Functional [ftcn]
Standard [qlco]
Pharmacotherapy [topp]
Echocardiography [diap]
Left ventricular ejection fraction [clna]
Informed Consent [rnlw]
Extract [sbst]
mg% [qnco]
MATCHING [resa]
placebo [topp]
Twice daily [tmco]
Primary Outcome Measure [inpr]
Left ventricular ejection fraction [clna]
weeks [tmco]
secondary [neop]
Measure [qnco]
included [ftcn]
New York Heart Association Class [fndg]
Functional [ftcn]
Distance [qnco]
Covered [ftcn]
Walk [dora]
Test [lbpr]
III [inpr]
Quality of life [idcn]
Kansas City cardiomyopathy questionnaire [inpr]
Plasma [bdsu]
Natriuretic Peptide, Brain [aapp, horm, phsu]
Plasma [bdsu]
Cytokines [aapp, imft]
Interleukin-6 [aapp, imft]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
tumor necrosis factor-alpha [aapp, imft]
VI [inpr]
Oxidative Stress [comd]
Marker [clna]
Thiobarbituric Acid Reactive Substances [irda, orch]
Red blood cell [cell]
Superoxide Dismutase [aapp, enzy, phsu]
Red blood cell [cell]
CATALASE [aapp, enzy]
GLUTATHIONE, RED-CELL [aapp, irda]
Blood [tisu]
GSH [aapp, bacs]
weeks [tmco]
Safety [hcpp]
Assessment [hlca]
Adverse event [fndg]
Monitoring [hlca]
Laboratory [mnob, orgt]
Investigations [hlca]
SD [fndg]
Interquartile Range [qnco]
Intention [menp]
Appropriate [qlco]
2-Sided Test [resa]
Statistical [ocdi]
P-Value [qnco]
considered [idcn]
Extract [sbst]
Well [qlco]
Left ventricular ejection fraction [clna]
P NOS [aapp, imft]
secondary [neop]
Measure [qnco]
Preservation [lbpr]
Red blood cell [cell]
catalase activity [moft]
U/g Hemoglobin [qnco]
P NOS [aapp, imft]
Compared [acty]
placebo [topp]
Percentage [qnco]
increases [ftcn]
Occurred [acty]
Distance [qnco]
Covered [ftcn]
Red blood cell [cell]
Superoxide Dismutase [aapp, enzy, phsu]
Red blood cell [cell]
CATALASE [aapp, enzy]
Red blood cell [cell]
GSH [aapp, bacs]
Symptom severity [fndg]
Stability [qlco]
Domain [ftcn]
Kansas City cardiomyopathy questionnaire [inpr]
Patients [podg]
Extract [sbst]
placebo [topp]
Post [tmco]
subgroups [virs]
Patients [podg]
Improved [qlco]
Extract [sbst]
Left ventricular ejection fraction [clna]
Chronic heart failure [dsyn]
Patients [podg]
weeks [tmco]
Improvement [cnce]
functional capacity [topp]
Antioxidant [phsu]
Reserve [acty]
Symptom [sosy]
Quality of life [idcn]
Domain [ftcn]
Patients [podg]
Reserve [acty]
